FDA Report - FDAs Work to Combat the COVID-19 Pandemic The FDA “Work to Combat the COVID-19 Pandemic” overview (data current as of April 2022) summarizes FDA’s cross-center actions on vaccines, therapeutics, diagnostics/devices, supply chain resilience, inspections/fraud enforcement, and regulatory science. It highlights scale and mechanisms such as EUAs and postmarket monitoring, expanded data infrastructure and real-world evidence efforts, device/test oversight and communications, and initiatives to prevent shortages and intercept fraudulent or contaminated products. It also notes crosscutting research and equity-focused work intended to strengthen preparedness for future public health emergencies. primary file regulatory reg-articles-misc 2022-07-01_FDA Report - FDAs Work to Combat the COVID-19 Pandemic.md regulatory/reg-articles-misc/2022-07-01_FDA Report - FDAs Work to Combat the COVID-19 Pandemic.md 2022_07_01 pdf Public Domain 4827 6335 gfile-url xfile-github-download-url pdf-gdrive-url pdf-github-url github-markdown-url github-markdown-download-url web-pdf-url web-slides-url youtube-url web-url